Free tool
Healthcare stocks
We cover 241 companies in the Healthcare sector. The median market value in the group is $1.14B. Across the group, the median move over the past trading day is +0.54%. 59% of the 230 with a 200-day average trade above it. Price change over the past year runs from −38.1% to +70.5% across the middle 80 percent of the group, with a median of −1.3%. Across the group, 3 companies currently carry a tier A volume signal.
Other lists in this group
Table
241 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| GIS.DE | Gilead Sciences, Inc. | $184.35B | Large cap | +33.64% |
| PFE.DE | Pfizer Inc. | $161.11B | Large cap | +22.96% |
| DAP.DE | Danaher Corporation | $151.59B | Large cap | +6.90% |
| VX1.DE | Vertex Pharmaceuticals Incorporated | $139.82B | Large cap | +41.64% |
| BRM.DE | Bristol-Myers Squibb Company | $137.92B | Large cap | +50.84% |
| IUI1.DE | Intuitive Surgical, Inc. | $131.98B | Large cap | −21.06% |
| SYK.DE | Stryker Corporation | $126.78B | Large cap | +34.90% |
| 2M6.DE | Medtronic plc | $117.57B | Large cap | +2.65% |
| SNW.DE | Sanofi | $109.40B | Large cap | −2.82% |
| SAN.PA | Sanofi | $109.36B | Large cap | −2.60% |
| GSK.L | GSK plc | $104.16B | Large cap | +30.59% |
| GS71.DE | GSK plc | $103.63B | Large cap | +34.79% |
| A58.DE | Elevance Health, Inc. | $87.59B | Large cap | −19.30% |
| ESL.DE | EssilorLuxottica Société anonyme | $85.76B | Large cap | −39.11% |
| EL.PA | EssilorLuxottica Société anonyme | $85.31B | Large cap | −38.15% |
| RGO.DE | Regeneron Pharmaceuticals, Inc. | $84.24B | Large cap | −5.91% |
| CGN.DE | The Cigna Group | $74.86B | Large cap | −8.78% |
| MRK.DE | Merck KGaA | $70.28B | Large cap | +32.17% |
| BSX.DE | Boston Scientific Corporation | $69.12B | Large cap | −53.11% |
| 0QF.DE | Moderna, Inc. | $59.07B | Large cap | +550.51% |
| BAYN.DE | Bayer Aktiengesellschaft | $56.25B | Large cap | +76.91% |
| BAY.WA | Bayer Aktiengesellschaft | $55.90B | Large cap | +76.59% |
| EWL.DE | Edwards Lifesciences Corporation | $52.39B | Large cap | +11.65% |
| BOX.DE | Becton, Dickinson and Company | $51.84B | Large cap | +1.73% |
| SHL.DE | Siemens Healthineers AG | $51.23B | Large cap | −14.18% |
| H6D0.DE | Haleon plc | $44.85B | Large cap | +5.39% |
| HLN.L | Haleon plc | $44.62B | Large cap | +2.68% |
| IX1.DE | IDEXX Laboratories, Inc. | $44.14B | Large cap | +17.97% |
| QTS.DE | IQVIA Holdings Inc. | $43.01B | Large cap | −4.04% |
| VEE.DE | Veeva Systems Inc. | $40.02B | Large cap | +13.43% |
| 2U3.DE | Alcon Inc. | $35.20B | Large cap | −7.70% |
| ILU.DE | Illumina, Inc. | $34.08B | Large cap | +129.80% |
| DC4.DE | DexCom, Inc. | $33.35B | Large cap | +21.06% |
| IDP.DE | Biogen Inc. | $32.39B | Large cap | +65.32% |
| DUL.DE | Alnylam Pharmaceuticals, Inc. | $32.28B | Large cap | −10.21% |
| ZOE.DE | Zoetis Inc. | $32.08B | Large cap | −49.47% |
| FRE.DE | Fresenius SE & Co. KGaA | $30.43B | Large cap | +1.64% |
| 22UA.DE | BioNTech SE | $28.28B | Large cap | +14.09% |
| MTO.DE | Mettler-Toledo International Inc. | $27.92B | Large cap | +13.15% |
| PHI1.DE | Koninklijke Philips N.V. | $26.37B | Large cap | +3.22% |
| DIM.PA | Sartorius Stedim Biotech S.A. | $21.78B | Large cap | +11.64% |
| 56S1.DE | Sartorius Stedim Biotech S.A. | $21.77B | Large cap | +11.32% |
| GMAB.CO | Genmab A/S | $20.69B | Large cap | +36.19% |
| GE9.DE | Genmab A/S | $20.65B | Large cap | −11.12% |
| SRT3.DE | Sartorius Aktiengesellschaft | $19.68B | Large cap | +25.88% |
| VIA.DE | Viatris Inc. | $19.41B | Large cap | +67.32% |
| QS51.DE | Straumann Holding AG | $18.40B | Large cap | −1.10% |
| SOBI.ST | Swedish Orphan Biovitrum AB (publ) | $16.99B | Large cap | +61.26% |
| IPN.PA | Ipsen S.A. | $15.97B | Large cap | +40.80% |
| COLO-B.CO | Coloplast A/S | $15.96B | Large cap | −20.60% |
| CBHD.DE | Coloplast A/S | $15.94B | Large cap | +7.91% |
| SRT.DE | Sartorius Aktiengesellschaft | $15.54B | Large cap | +21.79% |
| ESF0.DE | Eurofins Scientific SE | $14.67B | Large cap | +12.65% |
| ERF.PA | Eurofins Scientific SE | $14.64B | Large cap | +15.60% |
| ORNBV.HE | Orion Oyj | $13.16B | Large cap | +21.01% |
| ORNAV.HE | Orion Oyj | $13.11B | Large cap | +21.27% |
| FME.DE | Fresenius Medical Care AG | $12.64B | Large cap | −2.61% |
| REC.MI | Recordati Industria Chimica e Farmaceutica S.p.A. | $12.57B | Large cap | +1.80% |
| SN.L | Smith & Nephew plc | $12.18B | Large cap | −22.42% |
| AFW.DE | Align Technology, Inc. | $11.26B | Large cap | −54.37% |
| BIM.PA | bioMérieux S.A. | $10.22B | Large cap | −35.91% |
| ABVX.PA | ABIVAX Société Anonyme | $10.21B | Large cap | +48.91% |
| DEMANT.CO | Demant A/S | $9.36B | Mid cap | +17.12% |
| WDH1.DE | Demant A/S | $9.33B | Mid cap | −5.53% |
| KRK.WA | Krka, d. d. | $9.20B | Mid cap | +30.59% |
| QIA.DE | Qiagen N.V. | $8.99B | Mid cap | −6.73% |
| ALK-B.CO | ALK-Abelló A/S | $7.26B | Mid cap | +5.09% |
| GETI-B.ST | Getinge AB (publ) | $7.01B | Mid cap | +20.89% |
| HLUN-B.CO | H. Lundbeck A/S | $6.47B | Mid cap | +8.99% |
| HLUN-A.CO | H. Lundbeck A/S | $6.40B | Mid cap | +29.71% |
| CTEC.L | Convatec Group PLC | $6.01B | Mid cap | −1.95% |
| SECT-B.ST | Sectra AB (publ) | $5.63B | Mid cap | −17.02% |
| HIK.L | Hikma Pharmaceuticals PLC | $4.61B | Mid cap | −9.62% |
| OBCK.DE | Ottobock SE & Co. KGaA | $4.40B | Mid cap | +0.68% |
| 1SXP.DE | SCHOTT Pharma AG & Co. KGaA | $4.08B | Mid cap | +1.26% |
| BBZA.DE | BB Biotech AG | $3.87B | Mid cap | +7.22% |
| MCOV-B.ST | Medicover AB (publ) | $3.85B | Mid cap | −8.20% |
| CAMX.ST | Camurus AB (publ) | $3.79B | Mid cap | −15.35% |
| FIE.DE | Fielmann Group AG | $3.79B | Mid cap | −27.31% |
| 22Z.DE | Zealand Pharma A/S | $3.37B | Mid cap | −28.16% |
| ZEAL.CO | Zealand Pharma A/S | $3.34B | Mid cap | −25.94% |
| VIRP.PA | Virbac SA | $3.24B | Mid cap | −2.08% |
| AFX.DE | Carl Zeiss Meditec AG | $3.19B | Mid cap | −24.83% |
| BIOA-B.ST | BioArctic AB (publ) | $3.00B | Mid cap | +12.31% |
| ASKER.ST | Asker Healthcare Group AB (publ) | $2.99B | Mid cap | −24.65% |
| B72.DE | AtaiBeckley Inc. | $2.79B | Mid cap | +59.69% |
| AMBU-B.CO | Ambu A/S | $2.69B | Mid cap | −19.13% |
| BV3.DE | Bavarian Nordic A/S | $2.55B | Mid cap | +15.65% |
| EMEIS.PA | emeis Société anonyme | $2.55B | Mid cap | +10.93% |
| BAVA.CO | Bavarian Nordic A/S | $2.51B | Mid cap | −7.97% |
| DRW3.DE | Drägerwerk AG & Co. KGaA | $2.45B | Mid cap | +70.53% |
| ONT.L | Oxford Nanopore Technologies plc | $2.41B | Mid cap | −2.24% |
| DMP.DE | Dermapharm Holding SE | $2.31B | Mid cap | +27.27% |
| EKTA-B.ST | Elekta AB (publ) | $2.20B | Mid cap | +26.10% |
| HCM.L | HUTCHMED (China) Limited | $2.16B | Mid cap | −18.08% |
| GN.CO | GN Store Nord A/S | $2.13B | Mid cap | −18.50% |
| ALIF-B.ST | AddLife AB (publ) | $2.08B | Mid cap | −7.20% |
| GNS.L | Genus plc | $2.08B | Mid cap | −12.94% |
| NANO.PA | Nanobiotix S.A. | $2.05B | Mid cap | +358.21% |
| VIMIAN.ST | Vimian Group AB (publ) | $1.99B | Small cap | +12.01% |
| EMBLA.CO | Embla Medical hf. | $1.93B | Small cap | −6.94% |
| GXE.DE | Lakefront Biotherapeutics NV | $1.93B | Small cap | −44.50% |
| DRW8.DE | Drägerwerk AG & Co. KGaA | $1.84B | Small cap | +53.42% |
| ATT.ST | Attendo AB (publ) | $1.77B | Small cap | +80.74% |
| ALVO-SDB.ST | Alvotech | $1.74B | Small cap | −39.57% |
| CLARI.PA | Clariane SE | $1.67B | Small cap | −6.95% |
| BONEX.ST | Bonesupport Holding AB (publ) | $1.57B | Small cap | −28.26% |
| DIA.WA | Diagnostyka S.A. | $1.54B | Small cap | −17.76% |
| NOLA-B.ST | Nolato AB (publ) | $1.50B | Small cap | −7.00% |
| RDC.DE | Redcare Pharmacy NV | $1.49B | Small cap | −23.82% |
| AMBEA.ST | Ambea AB (publ) | $1.45B | Small cap | +38.66% |
| GDS.PA | Ramsay Générale de Santé SA | $1.42B | Small cap | +9.50% |
| F9L.F | Joincare Pharmaceutical Group Industry Co.,Ltd. | $1.39B | Small cap | −48.41% |
| VITR.ST | Vitrolife AB (publ) | $1.35B | Small cap | −30.23% |
| CHEMM.CO | ChemoMetec A/S | $1.33B | Small cap | −3.94% |
| UPR.L | Uniphar plc | $1.33B | Small cap | +6.94% |
| SPI.L | Spire Healthcare Group plc | $1.28B | Small cap | +7.25% |
| BIOG-B.ST | BioGaia AB (publ) | $1.23B | Small cap | +13.96% |
| CVSG.L | CVS Group plc | $1.20B | Small cap | +2.05% |
| IVA.PA | Inventiva S.A. | $1.14B | Small cap | −14.63% |
| RHK.DE | RHÖN-KLINIKUM Aktiengesellschaft | $1.14B | Small cap | +24.49% |
| TTALO.HE | Terveystalo Oyj | $1.14B | Small cap | −22.31% |
| SPH.WA | Sopharma AD | $1.13B | Small cap | −38.71% |
| PHIL.MI | Philogen S.p.A. | $1.11B | Small cap | +4.75% |
| GUBRA.CO | Gubra A/S | $1.02B | Small cap | +4.79% |
| GXI.DE | Gerresheimer AG | $1.02B | Small cap | −39.73% |
| MEDCL.PA | MedinCell S.A. | $1.02B | Small cap | +41.92% |
| VETO.PA | Vetoquinol SA | $973.12M | Small cap | −6.37% |
| EUZ.DE | Eckert & Ziegler SE | $952.11M | Small cap | −24.60% |
| NEU.WA | NEUCA S.A. | $946.21M | Small cap | +15.02% |
| XVIVO.ST | Xvivo Perfusion AB (publ) | $929.27M | Small cap | +59.31% |
| PHN.MI | Pharmanutra S.p.A. | $921.01M | Small cap | +70.46% |
| DBV.PA | DBV Technologies S.A. | $901.25M | Small cap | +60.13% |
| SYNSAM.ST | Synsam AB (publ) | $873.75M | Small cap | +5.66% |
| MCAP.ST | MedCap AB (publ) | $864.73M | Small cap | −10.28% |
| DYVOX.ST | Dynavox Group AB (publ) | $850.75M | Small cap | −39.29% |
| OXB.L | Oxford Biomedica plc | $847.14M | Small cap | −9.81% |
| SFL.MI | Safilo Group S.p.A. | $839.99M | Small cap | +20.65% |
| AMS.L | Advanced Medical Solutions Group plc | $830.96M | Small cap | +38.01% |
| GNFT.PA | Genfit S.A. | $830.56M | Small cap | +310.45% |
| APOTEA.ST | Apotea AB (publ) | $822.73M | Small cap | −26.38% |
| ARJO-B.ST | Arjo AB (publ) | $802.95M | Small cap | −15.25% |
| UU8.F | Neurogene Inc. | $795.50M | Small cap | +165.60% |
| SNT.WA | Synektik Spólka Akcyjna | $774.15M | Small cap | +53.07% |
| EVT.DE | Evotec SE | $694.87M | Small cap | −45.75% |
| LBIRD.PA | Lumibird SA | $658.60M | Small cap | +57.43% |
| 2HQ0.DE | Tilray Brands, Inc. | $657.67M | Small cap | −67.56% |
| VLA.PA | Valneva SE | $627.96M | Small cap | −24.48% |
| AYJ.DE | Valneva SE | $619.77M | Small cap | −21.89% |
| CRW.L | Craneware plc | $588.10M | Small cap | −40.83% |
| EQS.PA | Equasens Société anonyme | $588.00M | Small cap | −25.98% |
| RAY-B.ST | RaySearch Laboratories AB (publ) | $564.79M | Small cap | −29.98% |
| BOI.PA | Boiron SA | $523.06M | Small cap | +21.99% |
| MEDI.OL | Medistim ASA | $512.66M | Small cap | +4.43% |
| J8J.F | TransThera Sciences (Nanjing), Inc. | $498.50M | Small cap | −90.91% |
| REG1V.HE | Revenio Group Oyj | $494.52M | Small cap | −38.54% |
| ALVIO.PA | Valerio Therapeutics Société anonyme | $492.64M | Small cap | +1198.08% |
| AGY.L | Allergy Therapeutics plc | $481.91M | Small cap | −30.00% |
| CVX.PA | Carvolix SA | $471.64M | Small cap | +293.42% |
| HNSA.ST | Hansa Biopharma AB (publ) | $450.66M | Small cap | +35.65% |
| AVCT.L | Avacta Group Plc | $440.62M | Small cap | +26.36% |
| CEVI.ST | CellaVision AB (publ) | $410.67M | Small cap | −5.28% |
| FYB.DE | Formycon AG | $410.04M | Small cap | −25.04% |
| LNA.PA | LNA Santé SA | $405.74M | Small cap | +11.88% |
| M12.DE | M1 Kliniken AG | $401.97M | Small cap | +37.84% |
| PRTC.L | PureTech Health plc | $398.28M | Small cap | −4.27% |
| NIOX.L | NIOX Group Plc | $392.35M | Small cap | −9.49% |
| EGTX.ST | Egetis Therapeutics AB (publ) | $390.51M | Small cap | +51.35% |
| CRNA.OL | Circio Holding ASA | $384.19M | Small cap | +1733.85% |
| VOX.WA | Voxel S.A. | $376.42M | Small cap | −18.11% |
| N3B.F | Anbio Biotechnology | $361.87M | Small cap | −83.42% |
| ALCLS.PA | Cellectis S.A. | $355.75M | Small cap | +27.74% |
| OPT.L | Optima Health plc | $355.51M | Small cap | +9.32% |
| HUM.ST | Humana AB (publ) | $350.23M | Small cap | +81.84% |
| ILM1.DE | Medios AG | $324.14M | Small cap | −26.32% |
| SBS.DE | Stratec SE | $322.43M | Small cap | −16.91% |
| NP5.DE | Newron Pharmaceuticals S.p.A. | $316.56M | Small cap | +47.70% |
| VICO.ST | Vicore Pharma Holding AB (publ) | $315.07M | Small cap | −1.29% |
| ANCR.L | Animalcare Group PLC | $314.33M | Small cap | +28.86% |
| MED.DE | MEDICLIN Aktiengesellschaft | $301.82M | Small cap | +75.81% |
| IDHC.L | Integrated Diagnostics Holdings plc | $298.80M | Small cap | +16.89% |
| PIHLIS.HE | Pihlajalinna Oyj | $283.18M | Small cap | −28.38% |
| SUS.ST | Surgical Science Sweden AB (publ) | $279.10M | Small cap | −48.69% |
| TSTL.L | Tristel plc | $276.02M | Small cap | +19.76% |
| TRMED.OL | Thor Medical ASA | $268.94M | Small cap | +135.13% |
| TNG.PA | Transgene SA | $263.11M | Small cap | −22.50% |
| XUP.DE | Genfit S.A. | $258.22M | Small cap | +166.82% |
| ALMDT.PA | Median Technologies SA | $256.00M | Small cap | +90.42% |
| IDD.DE | Innate Pharma S.A. | $243.27M | Small cap | −2.52% |
| IPH.PA | Innate Pharma S.A. | $240.15M | Small cap | +1.19% |
| CLN.WA | Celon Pharma S.A. | $235.59M | Small cap | −3.06% |
| ALERS.PA | Eurobio Scientific Société anonyme | $232.43M | Small cap | −21.89% |
| STIL.ST | Stille AB | $216.03M | Small cap | −4.26% |
| AOTI.L | AOTI, Inc. | $205.47M | Small cap | +159.09% |
| ICE.WA | Medinice S.A. | $204.25M | Small cap | +595.19% |
| NORDH.OL | Nordhealth AS | $204.13M | Small cap | −32.22% |
| LIK.DE | LIMES Schlosskliniken AG | $199.75M | Small cap | +70.66% |
| ORIOLA.HE | Oriola Oyj | $195.27M | Small cap | −21.98% |
| BLC.PA | Bastide Le Confort Médical SA | $189.61M | Small cap | −16.32% |
| CARA.ST | Carasent AB (publ) | $178.28M | Small cap | −10.62% |
| FLERIE.ST | Flerie AB (publ) | $172.03M | Small cap | −48.05% |
| SANION.ST | Saniona AB (publ) | $171.29M | Small cap | −12.37% |
| DXRX.L | Diaceutics PLC | $169.64M | Small cap | +4.36% |
| ALCGM.PA | Cegedim SA | $166.24M | Small cap | −4.56% |
| VME.DE | Viromed Medical AG | $164.76M | Small cap | +85.71% |
| ALSEN.PA | Sensorion SA | $164.03M | Small cap | −14.20% |
| BINV.ST | BioInvent International AB (publ) | $162.35M | Small cap | −23.46% |
| NYKD.OL | Nykode Therapeutics AS | $160.76M | Small cap | +204.86% |
| PHO.OL | Photocure ASA | $157.00M | Small cap | −13.46% |
| ENE.WA | Centrum Medyczne ENEL-MED S.A. | $154.41M | Small cap | +16.28% |
| S2B.WA | Syn2bio S.A. | $151.66M | Small cap | +76.47% |
| MRC.WA | Mercator Medical S.A. | $148.80M | Small cap | +35.88% |
| CRNO-B.ST | Cereno Scientific AB (publ) | $148.23M | Small cap | −53.59% |
| BICO.ST | BICO Group AB (publ) | $147.45M | Small cap | −17.00% |
| GENO.ST | Genovis AB (publ.) | $146.60M | Small cap | −16.91% |
| V5P.F | Vytrus Biotech, S.A. | $146.35M | Small cap | +225.93% |
| EKF.L | EKF Diagnostics Holdings plc | $145.56M | Small cap | −15.56% |
| PAX.ST | Paxman AB (publ) | $139.52M | Small cap | −21.45% |
| SCLP.L | Scancell Holdings plc | $136.80M | Small cap | −7.62% |
| SLV.WA | Selvita S.A. | $136.16M | Small cap | −9.21% |
| HPHA.DE | Heidelberg Pharma AG | $135.27M | Small cap | −31.15% |
| SEDANA.ST | Sedana Medical AB (publ) | $132.45M | Small cap | −22.05% |
| MVIR.ST | Medivir AB (publ) | $131.70M | Small cap | +4.73% |
| XI3.F | Bioceltix S.A. | $131.58M | Small cap | −28.67% |
| CTX.WA | Captor Therapeutics Spolka Akcyjna | $124.97M | Small cap | +80.49% |
| BVXP.L | Bioventix PLC | $124.26M | Small cap | −30.64% |
| CRAD-B.ST | C-Rad AB (publ) | $122.23M | Small cap | +6.49% |
| HAMLET-B.ST | Hamlet BioPharma AB (publ) | $121.98M | Small cap | −0.81% |
| BCX.WA | Bioceltix S.A. | $120.97M | Small cap | −20.77% |
| SCP.WA | Scope Fluidics S.A. | $120.06M | Small cap | −9.90% |
| S84.F | Scope Fluidics S.A. | $118.77M | Small cap | −10.43% |
| RVU.WA | Ryvu Therapeutics S.A. | $115.61M | Small cap | −36.99% |
| GBT.PA | Guerbet SA | $113.51M | Small cap | −61.92% |
| SYNACT.ST | SynAct Pharma AB | $111.82M | Small cap | +10.82% |
| FARON.HE | Faron Pharmaceuticals Oy | $111.17M | Small cap | −79.42% |
| AZT.OL | ArcticZymes Technologies ASA | $110.96M | Small cap | −27.02% |
| ALCJ.PA | Crossject Société Anonyme | $110.42M | Small cap | −2.63% |
| FARN.L | Faron Pharmaceuticals Oy | $110.28M | Small cap | −79.24% |
| ALECR.PA | Eurofins-Cerep SA | $107.03M | Small cap | −3.80% |
| DVYSR.ST | Devyser Diagnostics AB (publ) | $105.23M | Small cap | −60.78% |
| EAPI.PA | Euroapi S.A. | $104.85M | Small cap | −68.63% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.